### Institutional Regulations and Policies for Clinical Trials

#### 1. **General Eligibility Criteria**
   - **Age Restrictions**: Patients must be between 18 and 75 years old.
   - **Gender**: No restrictions unless specified by the trial protocol.
   - **Informed Consent**: All patients must provide informed consent prior to participation.
   - **Residency**: Patients must be residents of the country where the trial is conducted.
   - **Health Insurance**: Patients must have valid health insurance coverage.

#### 2. **Medical History Restrictions**
   - **Chronic Conditions**:
     - Severe Heart Disease (e.g., recent myocardial infarction, heart failure)
     - Uncontrolled Diabetes Mellitus
     - Active Cancer (excluding basal cell carcinoma and certain conditions in remission)
   - **Recent Surgeries**: Patients who have undergone major surgery within the last 6 months are not eligible.
   - **Mental Health**: Patients with severe psychiatric disorders, including schizophrenia and bipolar disorder, are excluded unless the trial specifically addresses these conditions.
   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.

#### 3. **Previous Trial Participation**
   - **Trial Washout Period**: Patients must not have participated in any other clinical trial within the last 30 days.
   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year to prevent overexposure to experimental treatments.
   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.
   - **Recent Trial Completion**: Patients must have completed their last trial at least 30 days prior to enrolling in a new trial to allow for proper assessment of any delayed adverse effects.
   - **Trial Outcomes**:
     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.
     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.

#### 4. **Medication and Treatment Restrictions**
   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.
   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.
   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.

#### 5. **Regulatory Compliance**
   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.
   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).
   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.

#### 6. **Special Considerations**
   - **Pregnancy and Nursing**: Pregnant or nursing women are excluded unless the trial is specifically designed for this population.
   - **Genetic Testing**: Trials involving genetic testing must have explicit consent from patients for genetic data collection and analysis.
   - **Patient Monitoring**: Patients must agree to regular monitoring and follow-up visits as specified by the trial protocol.
   - **BMI Restrictions**: Patients with a BMI outside the range of 18.5-35 may be excluded unless otherwise specified.
   - **Comorbid Conditions**: Patients with multiple comorbid conditions that may interfere with the study outcomes are excluded.

#### 7. **Emergency Contact and Support**
   - **Emergency Contact**: Patients must provide emergency contact information.
   - **Support Systems**: Patients must have access to appropriate support systems (e.g., caregiver, family member) to assist them throughout the trial.
